These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Prognosis
10 results:

  • 1. Hydroxygenkwanin suppresses peritoneal metastasis in colorectal cancer by modulating tumor-associated macrophages polarization.
    Xun J; Hu Z; Wang M; Jiang X; Liu B; Han Y; Gao R; Wu X; Zhang A; Yang S; Wang X; Yu X; Zhang Q
    Chem Biol Interact; 2024 Jun; 396():111038. PubMed ID: 38719169
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. colorectal cancer subtyping and prognostic model construction based on interleukin-related genes.
    Song J; Chen J; Chen Y; Wang Y; Zheng L; Yu H; Chen C
    Physiol Genomics; 2024 May; 56(5):367-383. PubMed ID: 38073490
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Intrinsic RIG-I restrains stat5 activation to modulate antitumor activity of CD8+ T cells.
    Jiang X; Lin J; Shangguan C; Wang X; Xiang B; Chen J; Guo H; Zhang W; Zhang J; Shi Y; Zhu J; Yang H
    J Clin Invest; 2023 May; 133(9):. PubMed ID: 36927693
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for colorectal cancer.
    Hao T; Yu H; Huang D; Liu Q
    Dis Markers; 2022; 2022():5884531. PubMed ID: 35928927
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma.
    Wang X; Liao X; Yu T; Gong Y; Zhang L; Huang J; Yang C; Han C; Yu L; Zhu G; Qin W; Liu Z; Zhou X; Liu J; Han Q; Peng T
    Int J Oncol; 2019 Oct; 55(4):805-822. PubMed ID: 31485610
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.
    Zhou W; Sun W; Yung MMH; Dai S; Cai Y; Chen CW; Meng Y; Lee JB; Braisted JC; Xu Y; Southall NT; Shinn P; Huang X; Song Z; Chen X; Kai Y; Cai X; Li Z; Hao Q; Cheung ANY; Ngan HYS; Liu SS; Barak S; Hao J; Dai Z; Tzatsos A; Peng W; Pei H; Han Z; Chan DW; Zheng W; Zhu W
    Oncogene; 2018 Jul; 37(29):3981-3997. PubMed ID: 29662190
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Therapeutic efficacy of CEP-33779, a novel selective JAK2 inhibitor, in a mouse model of colitis-induced colorectal cancer.
    Seavey MM; Lu LD; Stump KL; Wallace NH; Hockeimer W; O'Kane TM; Ruggeri BA; Dobrzanski P
    Mol Cancer Ther; 2012 Apr; 11(4):984-93. PubMed ID: 22334590
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Phospho-stat5 expression is associated with poor prognosis of human colonic adenocarcinoma.
    Mao YL; Li ZW; Lou CJ; Pang D; Zhang YQ
    Pathol Oncol Res; 2011 Jun; 17(2):333-9. PubMed ID: 21234733
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression of phosphorylated stat5 predicts expression of cyclin D1 and correlates with poor prognosis of colonic adenocarcinoma.
    Mao Y; Li Z; Lou C; Zhang Y
    Int J Colorectal Dis; 2011 Jan; 26(1):29-35. PubMed ID: 21079973
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock cancer Registry.
    Fietkau R; Zettl H; Klöcking S; Kundt G
    Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.